These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 10355532

  • 1. Soluble IL-6 and TNF receptors release by polymorphonuclear and mononuclear cells in cancer patients.
    Jablonska E.
    Neoplasma; 1999; 46(1):35-9. PubMed ID: 10355532
    [Abstract] [Full Text] [Related]

  • 2. Soluble IL-6 receptor release by PMNs and PBMC in patients with oral cavity cancer.
    Jabłońska E, Piotrowski L, Grabowska Z.
    Rocz Akad Med Bialymst; 1997; 42(1):99-106. PubMed ID: 9581469
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
    Jablońska E, Kiluk M, Piotrowski L, Grabowska Z, Markiewicz W, Jablonski J.
    Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
    [Abstract] [Full Text] [Related]

  • 4. TNF-alpha, IL-6 and their soluble receptor serum levels and secretion by neutrophils in cancer patients.
    Jabłońska E, Kiluk M, Markiewicz W, Piotrowski L, Grabowska Z, Jabłoński J.
    Arch Immunol Ther Exp (Warsz); 2001 Jun; 49(1):63-9. PubMed ID: 11266093
    [Abstract] [Full Text] [Related]

  • 5. Soluble TNF receptors release by polymorphonuclear cells and the serum levels in breast cancer patients before and after treatment.
    Jabłońska E, Kiluk M, Markiewicz W.
    Neoplasma; 1998 Jun; 45(1):17-20. PubMed ID: 9604996
    [Abstract] [Full Text] [Related]

  • 6. Changes in sIL-6R and sTNF-Rs release by PMNs and the serum levels in breast cancer patients at different stages of treatment.
    Jablonska E.
    Cytokine; 1998 Jul; 10(7):540-3. PubMed ID: 9702418
    [Abstract] [Full Text] [Related]

  • 7. TNFRs and IL-6R transmembrane receptors expression and release of their soluble forms by neutrophils and mononuclear cells from cancer patients.
    Jabłońska E, Jabioński J, Hołownia A, Iwaszkiewicz-Pawłowska A, Piotrowski L, Kiluk M, Grabowska SZ, Markiewicz W.
    Rocz Akad Med Bialymst; 2001 Jul; 46():113-25. PubMed ID: 11780554
    [Abstract] [Full Text] [Related]

  • 8. Relationship between TNF-alpha, IL-6 and their soluble receptors in the cultures of human PMN, PBMC and WBC.
    Jabłońska E.
    Rocz Akad Med Bialymst; 2001 Jul; 46():77-86. PubMed ID: 11780583
    [Abstract] [Full Text] [Related]

  • 9. Effect of soluble interleukin-6 receptor alpha and interleukin-6 secreted by polymorphonuclear leukocytes on tumor necrosis factor-alpha expression and its production by peripheral blood mononuclear cells.
    Jablonska E.
    Mediators Inflamm; 2002 Oct; 11(5):325-8. PubMed ID: 12467526
    [Abstract] [Full Text] [Related]

  • 10. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1997 Oct; 45(5-6):449-53. PubMed ID: 9437501
    [Abstract] [Full Text] [Related]

  • 11. Role of neutrophils in release of some cytokines and their soluble receptors.
    Jablonska E, Jablonski J, Holownia A.
    Immunol Lett; 1999 Dec 01; 70(3):191-7. PubMed ID: 10656673
    [Abstract] [Full Text] [Related]

  • 12. Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils.
    Jablonska E, Marcinczyk M.
    Mediators Inflamm; 2003 Jun 01; 12(3):179-83. PubMed ID: 12857602
    [Abstract] [Full Text] [Related]

  • 13. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Jun 01; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 14. Changes in soluble IL-6 receptor and IL-6 production by polymorphonuclear cells and whole blood cells of breast cancer patients.
    Jabłońska E, Pietruska Z.
    Arch Immunol Ther Exp (Warsz); 1998 Jun 01; 46(1):25-9. PubMed ID: 9510942
    [Abstract] [Full Text] [Related]

  • 15. Relative cytokine and cytokine inhibitor production by mononuclear cells and neutrophils.
    Xing L, Remick DG.
    Shock; 2003 Jul 01; 20(1):10-6. PubMed ID: 12813362
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 01; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 18. Release of soluble IL-6 receptor (IL-6sR) in comparison with release of soluble TNF receptors (sTNF-Rs) by PMNs and WBC derived from breast cancer patients.
    Jablonska E.
    Cancer Lett; 1997 Oct 28; 119(1):79-85. PubMed ID: 18372525
    [Abstract] [Full Text] [Related]

  • 19. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S, Xiao H, Fan Y, Wu F, Zhang Z, Li H, Yang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun 28; 25(6):325-9. PubMed ID: 12126553
    [Abstract] [Full Text] [Related]

  • 20. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease.
    Tinkle SS, Newman LS.
    Am J Respir Crit Care Med; 1997 Dec 28; 156(6):1884-91. PubMed ID: 9412570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.